Endurant Capital Management LP Veracyte, Inc. Transaction History

Endurant Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.8 Million - $3.03 Million	108,751 New	108,751 $1.81 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $1.92 Million - $3.71 Million	-87,343 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $2.92 Million - $4.35 Million	-80,868 Reduced 48.08%	87,343 $3.6 Million
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $997,359 - $1.48 Million	28,000 Added 19.97%	168,211 $7.81 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $4.62 Million - $7.94 Million	140,211 New	140,211 $5.61 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.